SCHEMBL17290337

SCHEMBL17290337

Cc1[nH]n(C)c(=O)c1-c1ccc(F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC11A2 P49281 4/20 0.55
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 3/20 0.46
POLB P06746 1/20 0.46
GAA P10253 3/20 0.44
ALOX15 P16050 1/20 0.44
PSD A5PKW4 2/20 0.43
MAPT P10636 2/20 0.42
ALKBH3 Q96Q83 1/20 0.41
KDM4E B2RXH2 2/20 0.41
CRHBP P24387 1/20 0.40
HTT P42858 1/20 0.40
CRHR2 Q13324 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NOD2 Q9HC29 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPK14 Q16539 1/20 0.38
HPD P32754 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23400130 0.85 KDM4E (0.47) SLC11A2MEN1KMT2ALMNAPOLB
SCHEMBL23398840 0.81 GAA (0.64) SLC11A2MEN1KMT2ALMNAGAA
SCHEMBL30992381 0.81 SLC11A2 (0.40) SLC11A2MEN1KMT2ALMNAPOLB
SCHEMBL10962285 0.73 KDM4E (0.41) SLC11A2MEN1KMT2ALMNAMAPT
SCHEMBL17290706 0.72 LMNA (0.48) MEN1KMT2ALMNAPOLBGAA
SCHEMBL11615177 0.69 SLC11A2 (0.49) SLC11A2MEN1KMT2ALMNAGAA
SCHEMBL23401873 0.69 ADORA2A (0.41) MEN1KMT2APOLBGAAALOX15
SCHEMBL11464791 0.68 SLC11A2 (0.48) SLC11A2MEN1KMT2ALMNAGAA
SCHEMBL10962176 0.68
SCHEMBL23402465 0.66 KDM4E (0.39) MEN1KMT2APOLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
EP-3148972-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals Inc. (US) 2017-04-05 EP disclosed
WO-2015183839-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2015-12-03 WO disclosed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 SLC11A2 3481/4885MEN1 3991/4885KMT2A 4665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.